At the end of the study, the curcumin group had lower levels of three blood markers of inflammation, including C - reactive protein (CRP), along with lower fasting blood sugar and hemoglobin A1c (a measure of longer term blood sugar levels).5 For comparison, the placebo group had higher blood sugar levels and increased inflammation after the eight weeks. (articles.mercola.com)
After eight weeks of treatment, both groups showed the same level of improvement in pain and functionality with only one big difference: In the drug group, 14 percent of the participants dropped out due to severe adverse effects; in the BCM - 95 curcumin group, not one person had to drop out. (mindbodygreen.com)
The conclusion of the study was that the curcumin group had a 65 % decreased risk of experiencing a heart attack in the hospital. (cancertutor.com)